Axim Biotechnologies, Inc.
AXIM· OTC
AXIMAxim Biotechnologies, Inc.
Filed Nov 19, 2012 · 10-Q · 50 days after period end · 0001514955-12-000029
| Metric | Q3 2012 | Q3 2011 |
|---|---|---|
| Revenue | $10.83K | $0.00 |
| Net Income | $2.40K | -$4.01K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 19, 2012 · 50 d after period end
